CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net income	$ 91,497	$ 90,499
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	42,991	37,591
Net changes in fair value of derivatives	(12,684)	291
Non-cash deferred lease expense	909	942
Amortization of unfavorable storage contracts	(2,768)	(2,748)
Earnings from equity investments	(1,266)	(1,629)
Distributions from equity investments	125	125
Other non-cash items	6,585	4,356
Change in assets and liabilities, net of amounts related to acquisitions:
Trade receivables	(90,186)	(13,102)
Construction and pipeline relocation receivables	1,219	(740)
Inventories	(104,980)	66,336
Prepaid and other current assets	447	24,418
Accounts payable	60,777	9,588
Accrued and other current liabilities	(36,867)	(30,347)
Other non-current assets	1,141	(1,116)
Other non-current liabilities	(4,558)	(2,047)
Net cash (used in) provided by operating activities	(47,618)	182,417
Cash flows from investing activities:
Capital expenditures	(109,864)	(67,186)
Proceeds from disposal of property, plant and equipment	21	358
Net cash used in investing activities	(109,843)	(66,828)
Cash flows from financing activities:
Net proceeds from issuance of LP units	52,217	349,564
Net proceeds from exercise of unit options	269
Payment of tax withholding on issuance of LTIP awards	(4,744)	(3,498)
Debt issuance costs	(10)
Borrowings under BPL Credit Facility	405,000	339,000
Repayments under BPL Credit Facility	(264,000)	(619,000)
Net borrowings (repayments) under BES Credit Facility	122,000	(81,300)
Distributions paid to noncontrolling interests	(1,953)	(2,295)
Distributions paid to unitholders	(124,954)	(100,272)
Net cash provided by (used in) financing activities	183,825	(117,801)
Net increase (decrease) in cash and cash equivalents	26,364	(2,212)
Cash and cash equivalents - Beginning of period	4,950	6,776
Cash and cash equivalents - End of period	$ 31,314	$ 4,564